Medtronic, a global leader in healthcare technology, today announced the appointment of Dr. Gerald “Jeb” Denny as Chief Medical Officer for its Acute Care & Monitoring (ACM) business.  

Dr. Denny brings extensive medical and product expertise to Medtronic, strengthening ACM’s medical strategy and reinforcing its leadership in the industry. Under his leadership, Medtronic aims to deepen its relationships with the healthcare community, customers, partners and professional societies globally. Dr. Denny will focus on delivering on the ACM vision of empowering healthcare professionals with world-class technology to personalize patient care, anytime, anywhere.  

“We’re honored to welcome Dr. Denny to Medtronic,” said Kate Benedict, president of the Medtronic Acute Care & Monitoring business, which is part of the company’s Medical Surgical Portfolio. “His relentless dedication to putting patient needs first aligns perfectly with our Mission, and I’m confident his expertise will play a key role in accelerating our innovation and growth.” 

Dr. Denny joins Medtronic from BD, where he led Medical Affairs for multiple technologies and businesses, including Urology and Critical Care, Smart Connected Care, and Vascular Access Devices. Prior to his roles at BD, Dr. Denny was Chief Medical Officer for the Medical Review Institute of America (MRIoA), a leader in utilization management. 

“I am incredibly excited to join Medtronic and the ACM business at a time when personalized patient care is at the forefront of healthcare,” said Dr. Denny. “I am deeply aligned with the Medtronic commitment to patient safety and innovation — and to revolutionizing the future of healthcare to alleviate pain, restore health, and extend life.”  

In his new role, Dr. Denny will continue to devote a portion of his time practicing medicine at the Physicians’ Care Clinic in Decatur, Georgia, ensuring he remains at the forefront of patient care, clinical practice, and innovation. 

Dr. Denny is board certified in both Nephrology and Internal Medicine and previously practiced as both a nephrologist and a hospitalist. He earned his doctorate in medicine at Wake Forest University School of Medicine and his Master of Science in Clinical Investigation at Vanderbilt University.  

About Medtronic 
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit medtronic.com and follow Medtronic on LinkedIn. 

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. 

Contacts: 
Amanda Bartschenfeld 
Communications
+1-763-514-9638 

Ryan Weispfenning 
Investor Relations 
+1-763-505-4626